E. coli O157 identifies a bacterial serogroup, a way of classifying E. coli by a surface characteristic. It is often discussed with O157:H7 outbreaks, but an O157 marker on a stool report is not a complete strain identification or proof of toxin production.
On this page
O157, H7 and Shiga toxin are different pieces of information
The familiar name O157:H7 combines two typing labels. Shiga toxins are separate disease-related characteristics. Clinical laboratories use methods that distinguish O157 and detect Shiga toxin or its genes when investigating possible STEC infection. These distinctions matter because non-O157 strains can also cause STEC illness. [1]
How the GI-MAP entry fits
The GI-MAP manufacturer lists O157 separately from EPEC/EHEC, stx1 and stx2. It specifically cautions that an O157 finding by itself is not a pathogenic marker. Read the EPEC/EHEC explanation and both toxin-gene results with it. [2]
What the result can and cannot tell you
A detected result indicates that the assay found its O157 target. It cannot, by itself, prove O157:H7 infection, measure toxin activity or predict kidney injury. An undetected O157 result does not exclude non-O157 STEC.
The useful next question is whether symptoms and the rest of the pathogen findings justify confirmation. For acute illness, a clinician may use a conventional stool panel, culture and public-health laboratory testing. The GI-MAP number is not a substitute for those clinical decisions.
Why symptoms take priority
Bloody diarrhea, substantial abdominal pain or signs of dehydration need prompt assessment. HUS is a serious complication of STEC; reduced urination, unusual bruising or profound fatigue during or after diarrheal illness should not wait for a repeat mail-in test. [1]
Common questions
Does O157 detected mean I have HUS?
No. HUS requires a clinical assessment and blood and kidney-function evaluation. A stool marker cannot diagnose it.
Can O157 be negative while a Shiga toxin gene is positive?
Yes, a Shiga toxin-producing organism need not belong to O157. The toxin finding still needs clinical interpretation.
Sources and review
Sources checked October 7, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- CDC: Information for clinicians about E. coli
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
Medical review of this article is pending. For a correction or source question, contact GI MAP Test.